United Arab Emirates Reveals Results of Using Drug “Sotrovimab” to Treat Crown



[ad_1]

United Arab Emirates reveals results of drug use

sotrofimab drug

UAE Health, in cooperation with the Abu Dhabi Health Department and the Dubai Health Authority, has revealed the efficacy of the drug “Sotrovimab” for the treatment of the crown in healing minor to moderate injuries in patients with high risk.

The Abu Dhabi media office said on its website that 6,175 patients in the United Arab Emirates received the drug Sotrofimab during the period from June 30 to July 13.

The office confirmed that the drug resulted in a complete cure for 97% of those who received it within 14 days of receiving it, preventing the disease from developing until death by 100% and preventing the patient from developing. enter intensive care by 99%.

He said about 52% of homeowners are 50 and over.

He said the drug has been received by patients with Covid-19 who suffer from various illnesses such as obesity, diabetes, heart disease, cancer and others.

The drug “Sutrovimab”, available in all “SEHA” facilities, contains monoclonal antibodies administered intravenously and is used to treat adults, pregnant women, children over 12 years of age and the most vulnerable groups who suffer chronic diseases.

Source: Emirati media



[ad_2]
Source link